Search details
1.
Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease.
Mol Psychiatry
; 28(3): 1312-1326, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36577843
2.
Risk of fall or fracture with concomitant use of prescription opioids and other medications in osteoarthritis patients.
Pharmacoepidemiol Drug Saf
; 33(3): e5773, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38419165
3.
Improving the accuracy of automated gout flare ascertainment using natural language processing of electronic health records and linked Medicare claims data.
Pharmacoepidemiol Drug Saf
; 33(1): e5684, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37654015
4.
Comparative Safety of Gout Treatment Strategies on Cardiovascular Outcomes Using Observational Data: Clone-censor-weight Target Trial Emulation Approach.
Epidemiology
; 34(4): 544-553, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-36943798
5.
Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom.
Diabetes Obes Metab
; 25(10): 2980-2988, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37395339
6.
Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study.
Clin Exp Rheumatol
; 41(1): 110-117, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-35616586
7.
Validation of serostatus of rheumatoid arthritis using ICD-10 codes in administrative claims data.
Pharmacoepidemiol Drug Saf
; 32(5): 586-591, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36728737
8.
Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease.
Gut
; 71(9): 1781-1789, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35387877
9.
Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy.
Circulation
; 143(8): 770-779, 2021 02 23.
Article
in English
| MEDLINE | ID: mdl-33302723
10.
Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 20(2): 314-324.e16, 2022 02.
Article
in English
| MEDLINE | ID: mdl-33387667
11.
Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study.
Ann Rheum Dis
; 81(6): 798-804, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35027405
12.
SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes.
Am J Kidney Dis
; 79(6): 858-867.e1, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34762974
13.
Risk of Hospitalization for Heart Failure in Patients With Hyperkalemia Treated With Sodium Zirconium Cyclosilicate Versus Patiromer.
J Card Fail
; 28(9): 1414-1423, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35470055
14.
Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis.
Cardiovasc Diabetol
; 21(1): 47, 2022 03 23.
Article
in English
| MEDLINE | ID: mdl-35321742
15.
Secular Trends in the Pharmacologic Treatment of Osteoporosis and Malignancy-Related Bone Disease from 2009 to 2020.
J Gen Intern Med
; 37(8): 1917-1924, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34100235
16.
Giant cell arteritis treatment patterns and rates of serious infections.
Clin Exp Rheumatol
; 40(4): 826-833, 2022 May.
Article
in English
| MEDLINE | ID: mdl-34905480
17.
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy.
Pharmacoepidemiol Drug Saf
; 31(2): 167-175, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34498314
18.
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data.
Pharmacoepidemiol Drug Saf
; 31(4): 467-475, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34908211
19.
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
Ann Intern Med
; 174(11): 1528-1541, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34570599
20.
Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout.
Eur Heart J
; 42(44): 4578-4588, 2021 11 21.
Article
in English
| MEDLINE | ID: mdl-34508567